22-Jan-2026
Download PDF
Alivus Life Sciences
Pursuant to Regulations 30 and 33 of the SEBI (LODR) 2015 we wish to inform you that the Board at its meeting held today approved the unaudited Financial Results for the Third Quarter and Nine Months ended December 31 2025.
Disclaimer: This content is for information only and should not be considered investment advice or a recommendation.
For grievances: [email protected]
Ask Value Research 
Widely read:
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.
